You are here

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, August 27, 2020 - 12:00
Condition:   Spinal Cord Injury
Interventions:   Biological: Autologous bone marrow-derived mononuclear cells;   Drug: Placebo
Sponsor:   Shanghai Changzheng Hospital
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Conditions:   Spinal Cord Injuries;   Paralysis
Interventions:   Other: Best Medical Management: Occupational and Physical Therapy;   Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor:   Allan Dietz
Recruiting
Posted: Monday, August 10, 2020 - 12:00
Condition:   Parkinson's Disease
Interventions:   Drug: MSC+placebo;   Drug: MSC;   Drug: Placebo
Sponsors:   The University of Texas Health Science Center, Houston;   Michael J. Fox Foundation for Parkinson's Research
Not yet recruiting
Posted: Tuesday, July 28, 2020 - 12:00
Condition:   Ischemic Stroke
Intervention:   Other: Autologous transplant
Sponsor:   Centre Hospitalier Universitaire Vaudois
Not yet recruiting
Posted: Wednesday, July 22, 2020 - 12:00
Condition:   Alzheimer Disease
Interventions:   Drug: AstroStem and Donepezil Placebo;   Drug: Donepezil and AstroStem Placebo
Sponsor:   Nature Cell Co. Ltd.
Not yet recruiting
Posted: Wednesday, June 17, 2020 - 12:00
Conditions:   Stroke;   Hemiparesis;Poststroke/CVA (Cerebrovascular Accident)
Intervention:   Device: MyHand Device
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
Posted: Wednesday, June 17, 2020 - 12:00
Condition:   Acute Stroke
Intervention:   Biological: UMSC01
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Recruiting
Posted: Wednesday, June 3, 2020 - 12:00
Condition:   Parkinson's Disease
Intervention:   Biological: Human Amniotic Epithelial Stem Cells
Sponsors:   Shanghai East Hospital;   Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Not yet recruiting
Posted: Friday, May 15, 2020 - 12:00
Condition:   Alzheimer Disease
Interventions:   Biological: low dosage MSCs-Exos administrated for nasal drip Dosage;   Biological: mild dosage MSCs-Exos administrated for nasal drip Dosage;   Biological: high dosage MSCs-Exos administrated for nasal drip Dosage
Sponsors:   Ruijin Hospital;   Cellular Biomedicine Group Ltd.
Not yet recruiting
Posted: Wednesday, May 6, 2020 - 12:00
Conditions:   Insomnia Chronic;   Mild Traumatic Brain Injury
Interventions:   Device: Sleep Healthy Using the Internet (SHUT-I);   Other: Education Control Program
Sponsors:   Henry M. Jackson Foundation for the Advancement of Military Medicine;   Uniformed Services University of the Health Sciences;   Center for Neuroscience and Regenerative Medicine (CNRM)
Not yet recruiting

Pages